Related Experiment Video
Updated: Jun 14, 2026
10:41
Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
Published on: February 17, 2017
LTBP-2 has multiple heparin/heparan sulfate binding sites
Mahroo K Parsi1, Julian R J Adams, John Whitelock
1Discipline of Pathology, School of Medical Sciences, University of Adelaide, Adelaide, South Australia 5005, Australia.
Summary
Latent transforming growth factor-beta-1 binding protein-2 (LTBP-2) interacts with heparin and cell surface proteoglycans, crucial for elastic fiber assembly and cell-matrix adhesion.
Area of Science:
- Biochemistry
- Cell Biology
- Extracellular Matrix Biology
Background:
- Latent transforming growth factor-beta-1 binding protein-2 (LTBP-2) is a protein associated with microfibrils during elastinogenesis.
- Its precise function remains poorly understood, despite its association with fibrillin-1.
- Heparan sulfate proteoglycans (HSPGs) are critical for normal fiber assembly, but their interaction with LTBP-2 is unclear.
Purpose of the Study:
- To investigate the molecular interactions between LTBP-2 and heparin/HSPGs.
- To identify the binding sites and characteristics of LTBP-2-heparin interactions.
- To understand the role of these interactions in elastic fiber assembly and cell-matrix attachment.
Main Methods:
- Solid-phase binding assays using recombinant LTBP-2 and its fragments with heparin-conjugated albumin (HAC).
- Analysis of binding specificity using heparin and chondroitin sulfate.
- Characterization of binding affinity (Kd) and dependence on divalent cations (Ca2+).
- Identification of specific heparin-binding sequences within LTBP-2 fragments.
- Testing interactions with cell surface HSPGs (syndecan-2, syndecan-4) and basement membrane HSPG (perlecan).
Main Results:
- LTBP-2 binds strongly and specifically to heparin, with high affinity (Kd = 0.9 nM).
- The N-terminal fragment (LTBP-2 NT(H)) showed strong heparin binding (Kd = 0.7 nM) independent of Ca2+, while the central fragment (LTBP-2 C(H)) bound weakly (Kd = 80 nM) and was Ca2+-dependent.
- Three heparin-binding sequences were identified in LTBP-2 NT(H), including one adjacent to the fibulin-5 binding site.
- LTBP-2 interacted strongly with syndecan-4 and perlecan in a heparin-inhibitable manner, but not with syndecan-2.
Conclusions:
- LTBP-2 interacts with heparin and HSPGs, particularly syndecan-4 and perlecan.
- These interactions are mediated by specific sequences in the N-terminal domain and can be Ca2+-dependent.
- HSPG-LTBP-2 interactions likely play a significant role in elastic fiber assembly and anchoring microfibrils to basement membranes.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:30Drug Binding to Blood Components
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
00:49Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...